Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer

被引:0
作者
K L Mahon
W Qu
J Devaney
C Paul
L Castillo
R J Wykes
M D Chatfield
M J Boyer
M R Stockler
G Marx
H Gurney
G Mallesara
P L Molloy
L G Horvath
S J Clark
机构
[1] Chris O’Brien Lifehouse,Cancer Research Division
[2] Garvan Institute of Medical Research/The Kinghorn Cancer Centre,undefined
[3] Sydney Medical School,undefined
[4] University of Sydney,undefined
[5] Royal Prince Alfred Hospital,undefined
[6] Menzies School of Health Research,undefined
[7] NHMRC Clinical Trials Centre,undefined
[8] University of Sydney,undefined
[9] Northern Haematology and Oncology Group,undefined
[10] SAN Clinic,undefined
[11] Westmead Hospital,undefined
[12] Calvary Mater Newcastle,undefined
[13] CSIRO Animal,undefined
[14] Food and Health Sciences,undefined
[15] St Vincent’s Clinical School,undefined
[16] University of NSW,undefined
来源
British Journal of Cancer | 2014年 / 111卷
关键词
castrate-resistant prostate cancer; chemotherapy; glutathione S-transferase 1; methylation; prognosis; therapeutic response;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1802 / 1809
页数:7
相关论文
共 227 条
[1]  
Armstrong AJ(2007)Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer J Clin Oncol 25 3965-3970
[2]  
Garrett-Mayer E(2005)Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy Clin Cancer Res 11 4037-4043
[3]  
Ou Yang YC(2008)Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients Ann N Y Acad Sci 1137 222-225
[4]  
Carducci MA(2001)Molecular detection of prostate cancer in urine by GSTP1 hypermethylation Clin Cancer Res 7 2727-2730
[5]  
Tannock I(2011)Circulating tumor cells as biomarkers in prostate cancer Clin Cancer Res 17 3903-3912
[6]  
de Wit R(2007)Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer Clin Cancer Res 13 7053-7058
[7]  
Eisenberger M(2007)Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer Clin Cancer Res 13 7053-7058
[8]  
Bastian PJ(2010)Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial Lancet 376 1147-1154
[9]  
Palapattu GS(2008)Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer Clin Cancer Res 14 6302-6309
[10]  
Lin X(2000)Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids Cancer Res 60 5941-5945